Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 3400 of 3546 entries
View as:

A Pilot Study to Determine the Relative Bioavailability of Mosapride 5mg From Two Candidate Formulations of GR107719B Relative to One 5mg Tablet of Reference Mosapride Citrate (GASMOTIN™) in Healthy Adult Human Subjects Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT02201316 Org: User:
Start: 02/03/14 End: 03/18/14 Due: 03/18/15

Evaluation of the Nicotine Lozenge in Relief of Provoked Acute Craving

Phase: N/A Priority: Normal
NCT ID: NCT01466361 Org: User:
Start: 09/30/10 End: 12/31/10 Due: 12/31/11

A Study to Evaluate the Effects of 3 Months Dosing With GW856553, as Assessed FDG-PET/CT Imaging

Phase: N/A Priority: Normal
NCT ID: NCT00633022 Org: User:
Start: 06/02/08 End: 12/03/09 Due: 12/03/10

A Study to Assess the Effect of SB 659032 on Platelet Function

Phase: N/A Priority: Normal
NCT ID: NCT01750827 Org: User:
Start: 09/30/04 End: 11/30/04 Due: 11/30/05

A Sourcing Study to Collect Human Blood Samples From Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT03493919 Org: User:
Start: 03/08/18 End: 05/27/22 Due: 05/27/23

Immune Memory Evaluation in Children Following a Primary Vaccination With Pneumococcal Conjugate Vaccines.

Phase: N/A Priority: Normal
NCT ID: NCT00333450 Org: User:
Start: 08/31/06 End: 12/31/06 Due: 12/31/07

A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT06472076 Org: User:
Start: 06/10/24 End: 09/19/29 Due: 09/19/30

A Repeat Dose Study in Healthy Volunteers Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK356278

Phase: N/A Priority: Normal
NCT ID: NCT01573819 Org: User:
Start: 11/24/11 End: 04/02/12 Due: 04/02/13

ADVAIR DISKUS® (Fluticasone Propionate/Salmeterol) Inhaler Versus SEREVENT DISKUS® (Salmeterol) Inhlaer On Inflammatory Cells And Markers In Chronic Obstructive Pulmonary Disease. ADVAIR DISKUS® and SEREVENT DISKUS® Inhalers Are Trademarks of the GSK Group of Companies.

Phase: N/A Priority: Normal
NCT ID: NCT00346749 Org: User:
Start: 12/31/06 End: 07/31/07 Due: 07/31/08

Trial to Evaluate Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2584786A in Healthy Children

Phase: N/A Priority: Normal
NCT ID: NCT01195779 Org: User:
Start: 09/30/10 End: 03/22/11 Due: 03/22/12

Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide

Phase: N/A Priority: Normal
NCT ID: NCT00279045 Org: User:
Start: 01/03/00 End: 06/19/06 Due: 06/19/07

Assessment of Comorbidities in Chronic Obstructive Pulmonary Disease (COPD) in European Symptomatic Subjects From Primary Care

Phase: N/A Priority: Normal
NCT ID: NCT01516528 Org: User:
Start: 11/17/11 End: 06/12/15 Due: 06/12/16

Long-Term Follow-up of Children for a 2-Year Period to Confirm the Safety and Immunogenicity of GSK 257049 Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00323622 Org: User:
Start: 04/30/05 End: 05/31/07 Due: 05/31/08

Bioavailability Study of Fixed Dose Combination (FDC) Dutasteride and Tamsulosin Hydrochloride (HCl) Relative to One Dutasteride and One Tamsulosin HCl Tablet in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02509104 Org: User:
Start: 07/30/15 End: 10/10/15 Due: 10/10/16

Study to Evaluate the Immune Response and Safety of GSK Biologicals' HPV Vaccine in Healthy Women Aged 18-35 Years

Phase: N/A Priority: Normal
NCT ID: NCT00345878 Org: User:
Start: 09/25/06 End: 12/21/07 Due: 12/21/08

Safety and Immunogenicity of 2 Formulations of Tuberculosis Vaccine GSK692342 Given at 0,1 Months to Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT00397943 Org: User:
Start: 11/15/06 End: 12/01/09 Due: 12/01/10

Antimicrobial Agent for Reducing Bacteria in Aerosols and Oral Cavity

Phase: N/A Priority: Normal
NCT ID: NCT02319668 Org: User:
Start: 02/01/15 End: 02/29/16 Due: 02/28/17

Safety and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' IPV Vaccine (PoliorixTM) in Toddlers

Phase: N/A Priority: Normal
NCT ID: NCT00920439 Org: User:
Start: 06/01/09 End: 08/03/09 Due: 08/03/10

Impact of Boostrix™ Maternal Vaccination on Morbidity and Mortality of Pertussis Disease in Infants ≤6 Weeks of Age, in Bogota, Colombia.

Phase: N/A Priority: Normal
NCT ID: NCT02569879 Org: User:
Start: 10/01/15 End: 04/14/18 Due: 04/14/19

Follow-up Study of GSK Biologicals' Human Papilloma Virus (HPV) Vaccine to Prevent Cervical Infection in Young Adults

Phase: N/A Priority: Normal
NCT ID: NCT00120848 Org: User:
Start: 11/30/03 End: 07/31/07 Due: 07/31/08

Exploratory Lapatinib (Positron Emission Tomography) PET Study in Subjects With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01290354 Org: User:
Start: 09/12/11 End: 03/18/13 Due: 03/18/14

Immunogenicity and Safety of GSK Biologicals' Boostrix Polio Vaccine in 3 and 4-year-old Children

Phase: N/A Priority: Normal
NCT ID: NCT01245049 Org: User:
Start: 04/01/11 End: 04/02/12 Due: 04/02/13

A Study in Healthy Japanese Participants to Evaluate the Safety and Pharmacokinetics of Otilimab

Phase: N/A Priority: Normal
NCT ID: NCT05304130 Org: User:
Start: 02/08/23 End: 05/04/23 Due: 05/04/24

A Fixed Dose Combination Amlodipine + Enalapril Bioavailability Study

Phase: N/A Priority: Normal
NCT ID: NCT01822639 Org: User:
Start: 04/03/13 End: 05/24/13 Due: 05/24/14

Treatment Of Impetigo With Topical SB-275833 Ointment, 1% Versus Topical Placebo Ointment

Phase: N/A Priority: Normal
NCT ID: NCT00133848 Org: User:
Start: 04/30/05 End: 01/31/06 Due: 01/31/07